Ligand validation:5FJI

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FJI_IMD_B_1883	64%	75%	0.131	0.931	0.25	0.71	-	-	0	0	100%	1
5FJI_IMD_A_1884	58%	88%	0.134	0.912	0.21	0.44	-	-	0	0	100%	1
5FJI_IMD_B_1882	48%	68%	0.166	0.91	0.35	0.88	-	-	0	0	100%	0.7
5FJI_IMD_B_1884	35%	75%	0.194	0.881	0.44	0.53	-	-	0	0	100%	1
5FJI_IMD_B_1885	32%	71%	0.2	0.875	0.53	0.57	-	-	0	0	100%	1
5FJI_IMD_A_1885	29%	75%	0.226	0.884	0.36	0.61	-	-	0	0	100%	1
5FJI_IMD_A_1883	10%	72%	0.389	0.892	0.58	0.5	-	-	0	0	100%	0.7
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
9FP4_IMD_A_402	100%	74%	0.036	0.993	0.23	0.76	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.